(MONROEVILLE, PA – April 4, 2011) RJ Lee Group welcomes Dr. Lin Wu as Director of Pharmaceutical and Biotechnical Services at their Monroeville headquarters. As Director, Dr. Wu will be expanding RJ Lee Group’s forensic approach to biopharma foreign particulate identification and characterization as well as nanotechnology efforts in materials characterization pertaining to product R&D for the bioscience industry.
Dr. Wu was formerly Dean of the Consortium Pharmaceutical & Biotechnology Training Center of the State of North Carolina (affiliated with Wake Technical College) in Raleigh. While in this position, he established and managed a state government-sponsored and cGMP-based biopharmaceutical operation facility to train personnel for the biopharmaceutical, medical devices and pharmaceutical industries. He also served as President and Chief Operating Officer for U.S. subsidiaries of Fresenius AG and Fresenius Kabi AG, German-based, multi-national healthcare conglomerate companies, and as Executive Vice President and Chief Technology Officer at Gull Laboratories, Inc. As Director of Molecular Biology at Gen Trak, Inc., he obtained the first FDA-approved HLA DNA genetic typing test in the U.S. Dr. Lin holds a doctorate in Microbiology and Infectious Diseases from the University of Alberta, Canada, and has a B. S. in Microbiology from Xiamen University in China. He is also the principal inventor of seven U.S. patents, two European patents, and one World Patent.
About RJ Lee Group
RJ Lee Group is recognized as an industry leader in providing innovative solutions to challenges in materials characterization, forensic engineering, and information management. For 30 years, we have been using our scientific expertise, instrumentation and technology to offer support strategies and provide solutions to our customers. RJ Lee Group is a 300-person company with headquarters located in Monroeville, Pa. For more information visit our website at www.rjleegroup.com.
For more information contact: Casey Bunker, Director of Marketing & Business Development at firstname.lastname@example.org or 724-325-1776.